<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29261737</article-id><article-id pub-id-type="pmc">5736199</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0189206</article-id><article-id pub-id-type="publisher-id">PONE-D-17-15838</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Ocular System</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Ocular System</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Biological Cultures</subject><subj-group><subject>Microbial Cultures</subject><subj-group><subject>Bacterial Cultures</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Microbial Control</subject><subj-group><subject>Antimicrobial Resistance</subject><subj-group><subject>Antibiotic Resistance</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Antimicrobial Resistance</subject><subj-group><subject>Antibiotic Resistance</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Ocular System</subject><subj-group><subject>Ocular Anatomy</subject><subj-group><subject>Cornea</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Ocular System</subject><subj-group><subject>Ocular Anatomy</subject><subj-group><subject>Cornea</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Surgical and Invasive Medical Procedures</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Ophthalmology</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pharmacology</subject><subj-group><subject>Drugs</subject><subj-group><subject>Antimicrobials</subject><subj-group><subject>Antibiotics</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Microbial Control</subject><subj-group><subject>Antimicrobials</subject><subj-group><subject>Antibiotics</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Surgical and Invasive Medical Procedures</subject><subj-group><subject>Ophthalmic Procedures</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Comparative efficacy of two different topical povidone-iodine 5% regimens in reducing conjunctival bacterial flora: A randomized parallel double-masked clinical trial</article-title><alt-title alt-title-type="running-head">Povidone-iodine in reducing conjunctival bacterial flora</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Barroso</surname><given-names>Let&#x000ed;cia Fernandes</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cazella</surname><given-names>Sarah Pereira</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nepomuceno</surname><given-names>Antonio Brunno</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Toscano</surname><given-names>Luiza</given-names></name><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Castilho</surname><given-names>Liliane &#x000c2;ngela de Souza</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Furlan</surname><given-names>Elo&#x000ed;sa Marcela Rueda</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Messias</surname><given-names>Andr&#x000e9;</given-names></name><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Supervision</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Scott</surname><given-names>Ingrid U.</given-names></name><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2652-0720</contrib-id><name><surname>Jorge</surname><given-names>Rodrigo</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Ophthalmology, Otorhinolaryngology and Head and Neck Surgery, School of Medicine of Ribeir&#x000e3;o Preto, University of S&#x000e3;o Paulo&#x02013;USP, Ribeir&#x000e3;o Preto, S&#x000e3;o Paulo, Brazil</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Ophthalmology, Penn State College of Medicine, Hershey, PA, United States of America</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Grzybowski</surname><given-names>Andrzej</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Poznan City Hospital, POLAND</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>rjorge@fmrp.usp.br</email></corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>12</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>12</volume><issue>12</issue><elocation-id>e0189206</elocation-id><history><date date-type="received"><day>12</day><month>5</month><year>2017</year></date><date date-type="accepted"><day>18</day><month>11</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 Barroso et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Barroso et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0189206.pdf"/><abstract><sec id="sec001"><title>Introduction</title><p>The increasing prevalence of multi-resistant bacteria is a major public health concern. Infections acquired during ophthalmic surgery are devastating. The purpose of the current study is to compare the proportion of eyes with negative bacterial cultures on all tested media after 1 versus 3 sequential drops of povidone-iodine (PI) 5% into the inferior conjunctival fornix.</p></sec><sec id="sec002"><title>Methods</title><p>Patients were randomly assigned to receive 1 (PI group) drop (at time 28 minutes) or 3 (PI plus group) sequential drops (at time 0, 20 minutes and 28 minutes) of PI 5% into the inferior conjunctival sac of one randomly selected eye. A swab culture was obtained from the inferior conjunctival fornix 5 minutes before and 30 minutes after time 0. Central corneal thickness (CCT) was measured shortly before time 0 and shortly after time 30. Conjunctival swabs were incubated aerobically in enriched Thioglycolate liquid medium (meat broth) and in three solid culture media (chocolate agar, trypticase soy agar with 5% sheep blood, and Sabouraud agar).</p></sec><sec id="sec003"><title>Results</title><p>There was no significant difference in the proportion of negative cultures after intervention between groups (p = 0.1638). Also in the PI group (n = 59), the proportion of eyes with negative cultures after PI (79.7%) did not differ significantly from baseline (76.3%; p = 0.7539). However in the PI plus group (n = 61), the proportion of eyes with all negative cultures after PI (85.3%) was significantly higher than before PI (70.5%) (p = 0.0177). There was no significant difference in mean CCT before and after the intervention in both groups.</p></sec><sec id="sec004"><title>Conclusion</title><p>Instillation of 3 sequential drops of PI was associated with a significant increase in the proportion of eyes with all negative cultures, while instillation of a single drop of PI was not associated with a significant increase in the proportion of negative cultures. Further study is warranted to determine whether the difference between the PI administration regimens is also associated with differences in the rates of postoperative ocular infections.</p></sec></abstract><funding-group><award-group id="award001"><funding-source><institution>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo (BR)</institution></funding-source><award-id>2010/17350-6</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2652-0720</contrib-id><name><surname>Jorge</surname><given-names>Rodrigo</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo (BR)</institution></funding-source><award-id>2013/03443-0</award-id><principal-award-recipient><name><surname>Barroso</surname><given-names>Let&#x000ed;cia Fernandes</given-names></name></principal-award-recipient></award-group><funding-statement>This work was supported by Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo&#x02014;FAPESP 2010/17350-6 (fapesp.br) RJ; Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo&#x02014;FAPESP 2013/03443-0 (fapesp.br) LFB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="4"/><page-count count="12"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec005"><title>Introduction</title><p>Studies have demonstrated that conjunctival and eyelid flora are the most common sources of postoperative endophthalmitis.[<xref rid="pone.0189206.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0189206.ref002" ref-type="bibr">2</xref>] In 82% of patients with endophthalmitis from whom microorganisms were isolated from the vitreous fluid, the bacteria were genetically indistinguishable from bacteria isolated from the eyelid, conjunctiva or nose of the patient.[<xref rid="pone.0189206.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0189206.ref002" ref-type="bibr">2</xref>]</p><p>The objective of antisepsis is to significantly reduce the number of microorganisms in the surgical field.[<xref rid="pone.0189206.ref002" ref-type="bibr">2</xref>] It is believed that reducing the number and growth of bacteria on the ocular surface and adnexa reduces the risk of postoperative endophthalmitis.[<xref rid="pone.0189206.ref003" ref-type="bibr">3</xref>]</p><p>Topical application of gatifloxacin for 3 days significantly enhances the proportion of eyes with negative bacterial cultures on all tested media compared to untreated eyes.[<xref rid="pone.0189206.ref004" ref-type="bibr">4</xref>] However, after instillation of PI, there was no significant difference in the proportion of eyes with negative bacterial cultures on all tested media between the untreated eyes (control) and eyes pretreated with topical gatifloxacin. These results suggest that the use of topical gatifloxacin in combination with PI for 3 days does not induce a greater reduction of bacterial colony counts than preoperative instillation of PI alone. Further, PI has not been associated with the development of antimicrobial resistance or the presence of more virulent species of bacteria, both of which have been reported in association with use of topical antibiotics.[<xref rid="pone.0189206.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0189206.ref005" ref-type="bibr">5</xref>]</p><p>The optimal number of PI drops, and optimal duration of PI contact on the ocular surface, to reduce ocular surface bacterial flora prior to ophthalmic surgery have not been established.[<xref rid="pone.0189206.ref006" ref-type="bibr">6</xref>] Although inexpensive and probably effective, a larger quantity of PI and/or longer duration of PI contact may be toxic to the ocular surface. The potential for ocular toxicity and the concerning emergence of resistant multi-resistant bacteria provide a strong rationale for detailed study of existing antiseptic methods.[<xref rid="pone.0189206.ref007" ref-type="bibr">7</xref>]</p><p>The purpose of the current study is to compare the proportion of eyes with negative bacterial conjunctival cultures on all tested media after instillation of 3 sequential drops of PI 5% over 28 minutes to the instillation of 1 drop of PI 5% into the inferior conjunctival fornix.</p></sec><sec sec-type="materials|methods" id="sec006"><title>Materials and methods</title><p>The study protocol adheres to the tenets of the Declaration of Helsinki and was approved by the local Institutional Review Board and Ethics Committee of the Hospital das Cl&#x000ed;nicas, University of S&#x000e3;o Paulo, Ribeir&#x000e3;o Preto, Brazil (2516/2010) on August 3<sup>rd</sup> 2010. The study is registered at <ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov/">www.clinicaltrials.gov</ext-link> (NCT01739920). All participants gave written informed consent before entering into the study.</p><p>Consecutive eligible patients evaluated in the Retina Section of the Department of Ophthalmology, School of Medicine of Ribeir&#x000e3;o Preto (HC-FMRP-USP), S&#x000e3;o Paulo, Brazil between May 2011 and October 2014, were invited to participate in this double-masked randomized clinical trial. The Ethics Committee of the Hospital das Cl&#x000ed;nicas, University of S&#x000e3;o Paulo, Ribeir&#x000e3;o Preto, Brazil adheres to Plataforma Brasil and makes available online study protocols at the time of protocol acceptance. The authors confirm that all ongoing and related trials for this drug/intervention are registered. All protocol changes were approved by the Ethics Committee of the Hospital das Cl&#x000ed;nicas, University of S&#x000e3;o Paulo, Ribeir&#x000e3;o Preto, Brazil.</p><sec id="sec007"><title>Patient eligibility</title><sec id="sec008"><title>Inclusion criteria</title><p>1) Age 18 years or older; 2) no systemic or ocular infection; 3) absence of autoimmune disease or immunosuppressive therapy; 4) no use of systemic or topic antibiotics in the preceding 30 days; 5) no previous ocular surgery or trauma in the study eye in the last 30 days; 6) no history of allergy to PI; 7) signed informed consent.</p></sec><sec id="sec009"><title>Exclusion criteria</title><p>1) Presence of blepharitis, ectropion, entropion, trichiasis or distichiasis; 2) diabetes mellitus; 3) any systemic condition that, at the discretion of the investigator, would predispose to infection, such as influenza; 4) inability to understand and/or unwilling to provide informed consent.</p></sec></sec><sec id="sec010"><title>Treatment assignment</title><p>One eye of each patient was randomly assigned to one of the two following study groups:</p><sec id="sec011"><title>PI plus group</title><p>Patients in the PI plus group underwent a baseline slit-lamp examination and had their central corneal thickness (CCT) measured by ultrasonic pachymeter (OcuScan Alcon RXP, Fortworth, USA). A sterile conjunctival swab (Cathc-All<sup>TM</sup>, Sample Collection Swab, Madison, USA) was used to take a culture of the conjunctiva 5 minutes before the first drop of PI 5% was instilled into the inferior conjunctival sac of the study eye. The time of the first PI 5% eye-drop instillation was considered time 0. At 20 minutes and at 28 minutes, a second and third PI 5% eye-drop, respectively, were administered into the inferior conjunctival sac of the study eye. At 30 minutes, a second conjunctival sac swab was obtained. At 35 minutes, CCT and slit-lamp examination were again performed to investigate for evidence of corneal epithelial toxicity.[<xref rid="pone.0189206.ref008" ref-type="bibr">8</xref>] Swabs were rotated completely 5 times with slight pressure against the inferior conjunctival fornix without contacting the other eye or any skin structure. Sampling was performed, using sterile gloves and a face mask, by the same researcher for all patients.</p></sec><sec id="sec012"><title>PI Group</title><p>Patients underwent the same procedures and swabs as patients in the PI plus group, except that the eye-drops administered at time 0 and at 20 minutes consisted of sterile saline solution 0.9% instead of PI 5% solution.</p><p>Before the application of any eye-drop (PI or saline) or any conjunctival swab, 1 drop of proximetacaine (Visonest&#x000ae;, Alcon, FortWorth, USA) was administered to the study eye in both groups.</p></sec></sec><sec id="sec013"><title>Microbiology assay</title><p>The samples obtained from conjunctival swabs were sent to the Microbiology Laboratory, University Hospital of Ribeir&#x000e3;o Preto Medical School, where they were incubated aerobically in enriched Thioglycolate liquid medium (meat broth) and in three solid culture media (Agar Chocolate, Trypticase Soy Agar with 5% sheep blood, and Agar Sabouraud). The Agar Sabouraud medium was incubated at 27&#x000b0;C. Agar Chocolate, Agar Blood and Thioglycolate media were incubated at 35 to 37&#x000b0;C. The cultures were examined daily starting 24 hours after seeding and up to 72 hours. The liquid Thioglycolate medium was sowed again as soon as it showed turbidity or after five days of incubation without turbidity. Sodium thiosulfate (0.5%) was added to the enriched Thioglycolate medium in order to neutralize the antiseptic iodine-povidone. [<xref rid="pone.0189206.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0189206.ref010" ref-type="bibr">10</xref>] Any microorganism that grew in the respective culture media was then isolated and identified with the automated Vitek 2 Technology system (bio-M&#x000e9;rieux&#x000ae;, Marcy-l'&#x000c9;toile, France). Tests to detect sensitivity to antibiotics were carried out using E-Test and the Vitek 2 Technology automated system with Advanced Expert System, which analyzes minimum inhibitory concentration patterns and detects the phenotype of the different microorganisms tested, following the criteria established by the Clinical and Laboratory Standards Institute.</p></sec><sec id="sec014"><title>Outcome measures</title><p>The primary outcome measure is the proportion of eyes with all negative bacterial cultures of the conjunctiva on all tested media after PI administration. Secondary outcomes include: 1) the proportion of eyes with negative bacterial cultures of the conjunctiva after PI administration adjusted by values before PI; 2) difference between the two PI groups with respect to change in CCT after PI administration compared to before PI.</p></sec><sec id="sec015"><title>Statistical analysis</title><p>Inter-group analysis was performed to compare the PI and PI plus groups with respect to the proportion of eyes with negative bacterial cultures on all tested media. Intra-group analysis was performed to compare the proportion of eyes with negative cultures on all tested media before and after PI instillation in each group.</p><p>For the inter-group analysis, the relative risk (RR) of achieving the primary outcome (all negative bacterial cultures after PI) was calculated (unadjusted inter-group analysis). We also used a generalized linear model (GLM) with logit binary function (adjusted inter-group analysis).[<xref rid="pone.0189206.ref011" ref-type="bibr">11</xref>] In GLM, the results obtained after treatment were considered as a dependent variable, the type of treatment as the independent variable and culture results before intervention as a covariate. This model resulted in an odds ratio (OR) for the comparison of the proportion of eyes with negative bacterial cultures on all tested media between the PI and PI plus groups adjusted by the proportion of eyes with negative bacterial cultures on all tested media before any intervention.</p><p>Comparisons of the intra-group results were performed using the McNemar exact test and OR for paired data.[<xref rid="pone.0189206.ref012" ref-type="bibr">12</xref>] The mean post-treatment pachymetry results were compared between the pre-treatment results using a covariance model analysis (ANCOVA). Missing values were not included in the statistic analysis.</p><p>Statistical significance was defined by p&#x0003c;0.05 and by a 95% confidence interval (CI). The analysis was performed using SAS v 9.4 (SAS Institute Inc., 2012). Losses related to the results of examinations were ignored and those patients were excluded (per-protocol analysis).</p></sec><sec id="sec016"><title>Sample size</title><p>Sample size calculation was performed based on previously published data and on a pilot study performed at our institution that demonstrated an increase of 20% in the number of negative cultures with the use of 3 PI drops (90% all negative cultures was found in the pilot study for PI plus) compared to the use of only 1 PI drop (70% all negative cultures was found in the pilot study for PI). The formula proposed by Sakpal 2010 for the calculation of sample size in clinical trials [<xref rid="pone.0189206.ref013" ref-type="bibr">13</xref>] was used. We considered the use of a two-tailed test with 80% power and a 5% level of significance. A sample size of 118 eyes, 59 in each arm, was considered sufficient to detect a difference of 20% in the number of negative cultures between groups. The results of the pilot study were analysed after protocol approval and before patient enrollment.</p></sec><sec id="sec017"><title>Randomization</title><p>A block randomization was performed using a fixed number of 4 participants with random distribution within the blocks. A randomization list was generated and remained in possession of HC-FMRP-USP staffs, who were not related to the inclusion of patients and evaluation of outcome in order to protect allocation concealment until the intervention was assigned. After patient allocation, the study eye was selected using a simple randomization method (flipping a coin).</p></sec><sec id="sec018"><title>Masking</title><p>A sham intervention was performed by the substitution of the first two PI drops by sterile saline 0.9% in the PI group. The application of the intervention was carried out by a physician not related to patient enrollment, randomization and outcome assessment. Recruiters, patients and outcome assessors were not informed of the PI administration regimen performed in each patient.</p></sec></sec><sec sec-type="results" id="sec019"><title>Results</title><p>The study population consists of 124 patients, including 61 in the PI group and 63 in the PI plus group (<xref ref-type="fig" rid="pone.0189206.g001">Fig 1</xref>). <xref ref-type="table" rid="pone.0189206.t001">Table 1</xref> summarizes the patient demographic and baseline characteristics. Culture results are unknown for two patients in each group due to inadequate sample (<xref ref-type="fig" rid="pone.0189206.g001">Fig 1</xref>). Those patients were excluded from the analysis.</p><fig id="pone.0189206.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0189206.g001</object-id><label>Fig 1</label><caption><title>Flow diagram of the study.</title><p>T = time; PI = povidone-iodine 5%; SS = saline solution.</p></caption><graphic xlink:href="pone.0189206.g001"/></fig><table-wrap id="pone.0189206.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0189206.t001</object-id><label>Table 1</label><caption><title>Patient demographic data and baseline characteristics.</title></caption><alternatives><graphic id="pone.0189206.t001g" xlink:href="pone.0189206.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">GROUP</th></tr><tr><th align="center" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">PI</th><th align="center" rowspan="1" colspan="1">PI plus</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1"><bold>Gender: n (%)</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">37 (60.66)</td><td align="center" rowspan="1" colspan="1">31 (49.20)</td></tr><tr><td align="center" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">24 (39.35)</td><td align="center" rowspan="1" colspan="1">32 (50.80)</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>Mean age in years</bold></td><td align="center" rowspan="1" colspan="1">63.90</td><td align="center" rowspan="1" colspan="1">62.34</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>(Standard deviation)</bold></td><td align="center" rowspan="1" colspan="1">(14.02)</td><td align="center" rowspan="1" colspan="1">(14.46)</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>Mean CCT</bold><xref ref-type="table-fn" rid="t001fn001"><sup><bold>a</bold></sup></xref>
<bold>before intervention (um)</bold></td><td align="center" rowspan="1" colspan="1">521.51</td><td align="center" rowspan="1" colspan="1">522.97</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>(Standard deviation)</bold></td><td align="center" rowspan="1" colspan="1">(33.75)</td><td align="center" rowspan="1" colspan="1">(36.04)</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>Positive culture before intervention (n)</bold></td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">10</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p><sup>a</sup>CCT = central corneal thickness</p></fn></table-wrap-foot></table-wrap><p>The number of eyes with negative cultures on all tested media in each group before and after treatment is displayed in <xref ref-type="table" rid="pone.0189206.t002">Table 2</xref>. The most commonly isolated pathogen was <italic>Staphylococcus epidermidis</italic>, cultured from 9 eyes before intervention and 9 eyes after intervention in the PI group; and cultured from 8 eyes before intervention and 5 eyes after intervention in the PI plus group. Other bacteria species were significantly heterogeneous.</p><table-wrap id="pone.0189206.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0189206.t002</object-id><label>Table 2</label><caption><title>Intra- and inter-group comparison of culture results.</title></caption><alternatives><graphic id="pone.0189206.t002g" xlink:href="pone.0189206.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" colspan="10" rowspan="1">Intra-group analysis<xref ref-type="table-fn" rid="t002fn005">&#x02020;</xref></th><th align="justify" rowspan="1" colspan="1">Inter-group analysis<xref ref-type="table-fn" rid="t002fn006"><sup>&#x02021;</sup></xref></th></tr><tr><th align="justify" rowspan="1" colspan="1"/><th align="center" colspan="3" rowspan="1"/><th align="center" rowspan="1" colspan="1">OR (95% CI)<xref ref-type="table-fn" rid="t002fn004"><sup>#</sup></xref></th><th align="justify" rowspan="1" colspan="1"/><th align="justify" colspan="3" rowspan="1"/><th align="center" rowspan="1" colspan="1">OR (95% CI)<xref ref-type="table-fn" rid="t002fn004"><sup>#</sup></xref></th><th align="center" rowspan="1" colspan="1">OR (95% CI)</th></tr><tr><th align="justify" rowspan="1" colspan="1"/><th align="center" colspan="3" rowspan="1">PI group</th><th align="center" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="t002fn003">*</xref></th><th align="justify" rowspan="1" colspan="1"/><th align="center" colspan="3" rowspan="1">PI plus group</th><th align="center" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="t002fn003">*</xref></th><th align="center" rowspan="1" colspan="1">p-value</th></tr><tr><th align="justify" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">+</th><th align="center" rowspan="1" colspan="1">-</th><th align="center" rowspan="1" colspan="1">Total</th><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">+</th><th align="center" rowspan="1" colspan="1">-</th><th align="center" rowspan="1" colspan="1">Total</th><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1"/></tr><tr><th align="center" rowspan="1" colspan="1">Intervention</th><th align="center" rowspan="1" colspan="1">after</th><th align="center" rowspan="1" colspan="1">after</th><th align="center" rowspan="1" colspan="1">n (%)</th><th align="justify" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Intervention</th><th align="center" rowspan="1" colspan="1">after</th><th align="center" rowspan="1" colspan="1">after</th><th align="center" rowspan="1" colspan="1">N (%)</th><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1"><bold>+</bold></td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">14 (23.7)</td><td align="center" rowspan="1" colspan="1">1.5 (0.4&#x02013;7.2)</td><td align="center" rowspan="1" colspan="1"><bold>+</bold></td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">18 (29.5)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>before</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>before</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">10.0 (1.4&#x02013;434.0)</td><td align="center" rowspan="1" colspan="1">2.2 (0.7&#x02013;6.8)</td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>-</bold></td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1">45 (76.3)</td><td align="center" rowspan="1" colspan="1">0.7539</td><td align="center" rowspan="1" colspan="1"><bold>-</bold></td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1">43 (70.5)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"><bold>before</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><bold>before</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">0.0117</td><td align="center" rowspan="1" colspan="1">0.1638</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Total n (%)</bold></td><td align="center" rowspan="1" colspan="1">12 (20.3)</td><td align="center" rowspan="1" colspan="1">47 (79.7)</td><td align="center" rowspan="1" colspan="1">59 (100.0)</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><bold>Total n (%)</bold></td><td align="center" rowspan="1" colspan="1">9 (14.7)</td><td align="center" rowspan="1" colspan="1">52 (85.3)</td><td align="center" rowspan="1" colspan="1">61 (100.0)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>+ = number of positive results</p></fn><fn id="t002fn002"><p>- = number of negative results.</p></fn><fn id="t002fn003"><p>(*)The exact version of Mc Nemar test was used for intra-groups comparisson.</p></fn><fn id="t002fn004"><p>(#) Odds ratio (OR), calculated for paired data.</p></fn><fn id="t002fn005"><p>(&#x02020;) For the intra-groups comparisson 0.5 was added to each cell for the OR calculation.</p></fn><fn id="t002fn006"><p>(&#x02021;) The inter-groups comparisson was calculated using a Generalized linear model.</p></fn></table-wrap-foot></table-wrap><p>Resistance to at least one of the tested antibiotics was found in a significant proportion bacteria isolated before or after intervention (<xref ref-type="table" rid="pone.0189206.t003">Table 3</xref>). The highest proportion of bacterial resistance was to the beta-lactam antibiotics. Quinolone-resistant organisms were isolated from 2 eyes in the PI group and 4 eyes in the PI plus group (<xref ref-type="table" rid="pone.0189206.t003">Table 3</xref>). Methicillin-resistant <italic>Staphylococcus epidermidis</italic> was isolated from 5 eyes in the PI group and 6 eyes in the PI plus group. Methicillin-resistant <italic>Staphylococcus aureus</italic> was isolated from one patient in each group. No vancomycin resistant organisms were detected in any of the samples.</p><table-wrap id="pone.0189206.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0189206.t003</object-id><label>Table 3</label><caption><title>Bacterial resistance in different antimicrobial classes.</title></caption><alternatives><graphic id="pone.0189206.t003g" xlink:href="pone.0189206.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Group</th><th align="justify" rowspan="1" colspan="1"/></tr><tr><th align="justify" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">PI</th><th align="center" rowspan="1" colspan="1">PI plus</th><th align="justify" rowspan="1" colspan="1"/></tr><tr><th align="justify" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">n (%)</th><th align="center" rowspan="1" colspan="1">n (%)</th><th align="justify" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="t003fn001">*</xref></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Resistance to at least one antibiotic</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Susceptible</td><td align="center" rowspan="1" colspan="1">5 (27.78)</td><td align="center" rowspan="1" colspan="1">4 (21.05)</td><td align="right" rowspan="1" colspan="1">0.7140</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Resistant</td><td align="center" rowspan="1" colspan="1">13 (72.22)</td><td align="center" rowspan="1" colspan="1">15 (78.95)</td><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Beta-lactam</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Susceptible</td><td align="center" rowspan="1" colspan="1">8 (44.44)</td><td align="center" rowspan="1" colspan="1">6 (33.33)</td><td align="right" rowspan="1" colspan="1">0.7332</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Resistant</td><td align="center" rowspan="1" colspan="1">10 (55.56)</td><td align="center" rowspan="1" colspan="1">12 (66.67)</td><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Methicillin (<italic>Staphylococcus spp</italic>.)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Susceptible</td><td align="center" rowspan="1" colspan="1">9 (56.25)</td><td align="center" rowspan="1" colspan="1">7 (50.00)</td><td align="right" rowspan="1" colspan="1">1.0000</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Resistant</td><td align="center" rowspan="1" colspan="1">7 (43.75)</td><td align="center" rowspan="1" colspan="1">7 (50.00)</td><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ceftazidime</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Susceptible</td><td align="center" rowspan="1" colspan="1">18 (100.00)</td><td align="center" rowspan="1" colspan="1">18 (94.74)</td><td align="right" rowspan="1" colspan="1">1.0000</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Resistant</td><td align="center" rowspan="1" colspan="1">0 (0.00)</td><td align="center" rowspan="1" colspan="1">1 (5.26)</td><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Quinolones</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Susceptible</td><td align="center" rowspan="1" colspan="1">16 (88.89)</td><td align="center" rowspan="1" colspan="1">15 (78.95)</td><td align="right" rowspan="1" colspan="1">0.6599</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Resistant</td><td align="center" rowspan="1" colspan="1">2 (11.11)</td><td align="center" rowspan="1" colspan="1">4 (21.05)</td><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Moxifloxacin</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Susceptible</td><td align="center" rowspan="1" colspan="1">16 (88.89)</td><td align="center" rowspan="1" colspan="1">16 (84.21)</td><td align="right" rowspan="1" colspan="1">1.0000</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Resistant</td><td align="center" rowspan="1" colspan="1">2 (11.11)</td><td align="center" rowspan="1" colspan="1">3 (15.79)</td><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Aminoglycosides</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="right" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Susceptible</td><td align="center" rowspan="1" colspan="1">11 (68.75)</td><td align="center" rowspan="1" colspan="1">15 (78.95)</td><td align="right" rowspan="1" colspan="1">0.7003</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Resistant</td><td align="center" rowspan="1" colspan="1">5 (31.25)</td><td align="center" rowspan="1" colspan="1">4 (21.05)</td><td align="right" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>*Fisher exact test</p></fn></table-wrap-foot></table-wrap><sec id="sec020"><title>Unadjusted inter-group analysis</title><p>Forty-seven of 59 patients in the PI group (79.7%) and 52 of 61 patients in the PI plus group (85.3%) showed a negative culture after intervention. The univariate RR of this comparison was 0.9345 (p = 0.4234; 95% CI = 0.7916 to 1.103). The univariate OR was 0.6779 (p = 0.4225; 95% CI = 0.2622 to 1.753).</p></sec><sec id="sec021"><title>Generalized linear model (GLM)&#x02013;adjusted inter-group analysis</title><p>There was no significant difference comparing values of culture results after intervention, considering culture results before intervention for adjustment p = 0.1638, OR = 2.2 (95%CI = 0.7&#x02013;6.8).</p></sec><sec id="sec022"><title>Intra-group analysis</title><p>In the PI group, the proportion of eyes with negative bacterial cultures on all tested media after PI (79.7%) did not differ significantly from baseline (76.3%) (p = 0.7539; OR = 1.5, 95% CI: 0.4 to 7.2) (<xref ref-type="table" rid="pone.0189206.t002">Table 2</xref>). In the PI plus group, the proportion of eyes with negative bacterial cultures on all tested media was significantly higher after PI (85.3%) than before PI (70.5%) (p = 0.0177; OR = 10.0, 95% CI: 1.4 to 434.0). In the PI plus group, patients were 10 times more likely to have all negative bacterial cultures after PI than before PI.</p></sec><sec id="sec023"><title>Central corneal thickness (CCT) evaluation</title><p>There was no significant difference between the PI and PI plus groups with respect to the mean change in CCT after PI compared to baseline (<xref ref-type="table" rid="pone.0189206.t004">Table 4</xref>). There was also no difference between the groups in mean CCT after PI, when adjusted for pachymetry values before treatment (p = 0.5228) (<xref ref-type="table" rid="pone.0189206.t004">Table 4</xref>).</p><table-wrap id="pone.0189206.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0189206.t004</object-id><label>Table 4</label><caption><title>Central corneal thickness (CCT) before and after intervention.</title></caption><alternatives><graphic id="pone.0189206.t004g" xlink:href="pone.0189206.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Mean Central Corneal Thickness (um)</th><th align="center" colspan="2" rowspan="1">Inter-group comparison</th></tr><tr><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1"/><th align="justify" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Diference (PI-PI plus)</th><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="justify" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">PI</th><th align="center" rowspan="1" colspan="1">PI plus</th><th align="center" rowspan="1" colspan="1">(CI 95%)</th><th align="center" rowspan="1" colspan="1">p-value<xref ref-type="table-fn" rid="t004fn002">*</xref></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>CCT</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Before intervention (95% CI)</td><td align="center" rowspan="1" colspan="1">521.51 (512.71&#x02013;530.30)</td><td align="center" rowspan="1" colspan="1">522.97 (513.74&#x02013;532.20)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">After intervention (95% CI)</td><td align="center" rowspan="1" colspan="1">522.85 (513.36&#x02013;532.33)</td><td align="center" rowspan="1" colspan="1">522.57 (511.68&#x02013;533.46)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Difference (before-after); (p-value)<xref ref-type="table-fn" rid="t004fn001"><sup>&#x02020;</sup></xref></td><td align="center" rowspan="1" colspan="1">1.34 (-2.30&#x02013;4.98); (0.4641)</td><td align="center" rowspan="1" colspan="1">-0.39 (-4.66&#x02013;3.88); (0.8544)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">After intervention (95% CI) (adjusted)<xref ref-type="table-fn" rid="t004fn004"><sup>#</sup></xref></td><td align="center" rowspan="1" colspan="1">523.62 (519.66&#x02013;527.59)</td><td align="center" rowspan="1" colspan="1">521.82 (517.92&#x02013;525.72)</td><td align="center" rowspan="1" colspan="1">1.80 (-3.76; 7.36)</td><td align="center" rowspan="1" colspan="1">0.5228</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>(&#x02020;) Intra-group comparison (before treatment x after treatment) were calculated using a paired t test.</p></fn><fn id="t004fn002"><p>(*) Statistical calculation for comparison between PI and PI plus groups were calculated using ANCOVA.</p></fn><fn id="t004fn003"><p>Values before treatment were used for adjustment (covariate).</p></fn><fn id="t004fn004"><p>(#) Mean values were adjusted using basal values from the ANCOVA model.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="conclusions" id="sec024"><title>Discussion</title><p>The increasing prevalence of multi-resistant bacteria is a significant public health concern.[<xref rid="pone.0189206.ref007" ref-type="bibr">7</xref>,<xref rid="pone.0189206.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0189206.ref015" ref-type="bibr">15</xref>] Such bacteria are commonly found in hospital environments, in patients who have undergone multiple surgical procedures and in patients hospitalized for a long period. [<xref rid="pone.0189206.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0189206.ref017" ref-type="bibr">17</xref>] Preventable factors contributing to the emergence of virulent multi-resistant micro-organisms include irresponsible use of antibiotics and inadequate antiseptic techniques.[<xref rid="pone.0189206.ref018" ref-type="bibr">18</xref>] Recently, the growing number of indications for intravitreal injections has resulted in a growing number of endophthalmitis cases after ophthalmologic procedures.[<xref rid="pone.0189206.ref003" ref-type="bibr">3</xref>]</p><p>The potentially devastating consequences of endophthalmitis and the relatively low penetration of most systemic antibiotics into the eye justify the need for studying how to optimize antiseptic procedures before invasive ocular procedures. Prior studies show that PI acts as an effective antiseptic agent prior to intraocular surgery.[<xref rid="pone.0189206.ref019" ref-type="bibr">19</xref>]</p><p>The proportion of eyes with negative bacterial cultures on all tested media before antiseptic treatment varied from 70.5 to 76.3% in the PI plus and PI group, respectively. In a previous study, 50.7 to 62.8% of patients had negative cultures on all tested media in the contralateral eyes of patients undergoing intravitreal injections before any antiseptic treatment.[<xref rid="pone.0189206.ref004" ref-type="bibr">4</xref>] Other studies reported lower rates: 28/272 (10.3%) patients selected for a prospective study of different anti-septic regimens had all negative cultures before any treatment.[<xref rid="pone.0189206.ref020" ref-type="bibr">20</xref>] The difference across various studies in the proportion of patients with all negative ocular surface cultures may be related to different microbiology techniques employed for conjunctival microorganisms culture: in the latter study, a specific medium developed at Research Foundation for Microbial Diseases of Osaka University was used and specimens were frozen within 1 hour after swab, while in our study specimens obtained from conjunctival swabs were immediately transferred to the Microbiology and Mycology Laboratory, where they were incubated aerobically in enriched Thioglycolate liquid medium.</p><p>The antibiotic resistance profile found in the current study raises significant concerns. The substantial proportion of eyes with methicillin-resistant and ceftazidime-resistant bacteria is especially concerning given that a combination of ceftazidime and vancomycin is one of the most widely used antibiotic regimens to treat endophthalmitis.[<xref rid="pone.0189206.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0189206.ref021" ref-type="bibr">21</xref>] Vancomycin resistance was not found in our sample, showing that this medication remains a good choice for endophthalmitis treatment in the geographic region studied. Topical moxifloxacin is frequently used for endophthalmitis prophylaxis.[<xref rid="pone.0189206.ref022" ref-type="bibr">22</xref>] The presence of moxifloxacin-resistant bacteria in our study and in previous reports,[<xref rid="pone.0189206.ref023" ref-type="bibr">23</xref>] reinforces the importance of research investigating optimization of anti-sepsis before invasive ocular interventions.</p><p>There is a lack of a uniformly accepted recommendation regarding the exposure time and the number of drops of 5% PI before intraocular procedures, although some studies about dosage and concentration have been performed. [<xref rid="pone.0189206.ref024" ref-type="bibr">24</xref>,<xref rid="pone.0189206.ref025" ref-type="bibr">25</xref>] The present intervention was chosen based on its capacity of applying of a greater amount of PI than a single drop and because it results in a greater exposure time. Studies have shown that 1 or 2 drops of 5% PI to the ocular surface can significantly reduce bacterial colonization and the risk of endophthalmitis.[<xref rid="pone.0189206.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0189206.ref026" ref-type="bibr">26</xref>,<xref rid="pone.0189206.ref027" ref-type="bibr">27</xref>] Our study demonstrated that a regimen with more frequent instillation (PI plus) started 30 minutes before intraocular intervention significantly reduced the bacterial load from the conjunctival flora. To the best of our knowledge, there is no study comparing the two different PI regimens employed in this study. However, there are some studies that indirectly corroborate and support the present study results.</p><p>Although the proportion of negative bacterial cultures on all tested media was significantly different before and after treatment in the PI plus group, the proportion of eyes with negative bacterial cultures on all tested media after PI administration was not different between both groups evaluated (univariate relative risk = 0.9345; 95% CI = 0.7916 to 1.103). This fact can be explained by an insufficient sensitivity of the univariate and of the multivariate models in detecting statistical differences probably because of a small sample size. This is an important limitation of this study. The absence of previous studies that compare similar regimens of PI instillation may have resulted in an underestimated sample size calculation.</p><p>The better antiseptic effect observed in the PI plus group compared to the PI group could be explained by a longer duration of PI exposure or a greater number of PI drops instilled. Hosseini et al. showed that longer exposure (15 minutes) to PI was more effective than shorter exposure (5 minutes) in preventing growth of bacterial isolates from patients diagnosed with postoperative endophthalmitis.[<xref rid="pone.0189206.ref028" ref-type="bibr">28</xref>] Moreover, Nentwich et al. concluded that copious use of PI in the preoperative period can result in a better irrigation of conjunctival crypts, resulting in a reduced risk of postoperative endophthalmitis.[<xref rid="pone.0189206.ref029" ref-type="bibr">29</xref>] Further study is warranted to investigate the relative importance of quantity of PI instilled versus duration of contact of the PI on the ocular surface.</p><p>One concern associated with PI eye drops is the potential for corneal toxicity.[<xref rid="pone.0189206.ref030" ref-type="bibr">30</xref>] Wille (1982) evaluated corneal swelling with pachymetry and endothelial cell loss with specular microscopy following cataract surgery and observed no increased postoperative corneal swelling when PI was used.[<xref rid="pone.0189206.ref031" ref-type="bibr">31</xref>] In the current study, there was no significant change in CCT after PI instillation in either group, but patient follow-up in the study was short. Of note, no patient demonstrated evidence of corneal toxicity during routine follow-up examinations in our department for at least two years after study completion.</p><p>Results of the current study indicate that instillation of three PI 5% eyedrops over 28 minutes significantly reduces the number of all negative bacterial cultures because of a greater number of PI drops instilled and/or because of the increased duration of exposure of the ocular surface to PI. This PI administration regimen may be more effective than instillation of a single eyedrop of PI 5%, although the relatively small sample size of the current study precludes definitive conclusions to be drawn. Further investigation is needed in order to optimize preoperative antisepsis with the ultimate goal of reducing the occurrence of postoperative endophthalmitis.</p></sec><sec sec-type="supplementary-material" id="sec025"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0189206.s001"><label>S1 CONSORT checklist</label><caption><title>CONSORT 2010 checklist.</title><p>Checklist of information to include when reporting a randomised trial.</p><p>(DOC)</p></caption><media xlink:href="pone.0189206.s001.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0189206.s002"><label>S1 Data Sheet</label><caption><title>Excel file with data used for analysis.</title><p>(XLSX)</p></caption><media xlink:href="pone.0189206.s002.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0189206.s003"><label>S1 Original Protocol</label><caption><title>Original Research Protocol.</title><p>(DOC)</p></caption><media xlink:href="pone.0189206.s003.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0189206.s004"><label>S1 Protocol Translation</label><caption><title>Protocol methods section translation.</title><p>English translation of the methods section extracted from the Original Research Protocol.</p><p>(DOC)</p></caption><media xlink:href="pone.0189206.s004.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank the clinical and laboratorial staff of the University Hospital of Ribeir&#x000e3;o Preto Medical School for their aid in the performance of the exams used for patient classification.</p></ack><ref-list><title>References</title><ref id="pone.0189206.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Speaker</surname><given-names>MG</given-names></name>, <name><surname>Milch</surname><given-names>FA</given-names></name>, <name><surname>Shah</surname><given-names>MK</given-names></name>, <name><surname>Eisner</surname><given-names>W</given-names></name>, <name><surname>Kreiswirth</surname><given-names>BN</given-names></name>. <article-title>Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis</article-title>. <source>Ophthalmology</source>. <year>1991</year>;<volume>98</volume>: <fpage>639</fpage>&#x02013;<lpage>49</lpage>&#x02013; discussion 650. <pub-id pub-id-type="pmid">2062496</pub-id></mixed-citation></ref><ref id="pone.0189206.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Bannerman</surname><given-names>TL</given-names></name>, <name><surname>Rhoden</surname><given-names>DL</given-names></name>, <name><surname>McAllister</surname><given-names>SK</given-names></name>, <name><surname>Miller</surname><given-names>JM</given-names></name>, <name><surname>Wilson</surname><given-names>LA</given-names></name>. <article-title>The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis</article-title>. <source>Arch Ophthalmol</source>. <year>1997</year>;<volume>115</volume>: <fpage>357</fpage>&#x02013;<lpage>361</lpage>. <pub-id pub-id-type="pmid">9076208</pub-id></mixed-citation></ref><ref id="pone.0189206.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Schwartz</surname><given-names>SG</given-names></name>, <name><surname>Flynn</surname><given-names>HW</given-names></name>. <article-title>Update on the prevention and treatment of endophthalmitis</article-title>. <source>Expert Rev Ophthalmol</source>. <year>2014</year>;<volume>9</volume>: <fpage>425</fpage>&#x02013;<lpage>430</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1586/17469899.2014.951331">10.1586/17469899.2014.951331</ext-link></comment>
<pub-id pub-id-type="pmid">26609317</pub-id></mixed-citation></ref><ref id="pone.0189206.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Moss</surname><given-names>JM</given-names></name>, <name><surname>Sanislo</surname><given-names>SR</given-names></name>, <name><surname>Ta</surname><given-names>CN</given-names></name>. <article-title>A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections</article-title>. <source>Ophthalmology</source>. Elsevier; <year>2009</year>;<volume>116</volume>: <fpage>1498</fpage>&#x02013;<lpage>1501</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ophtha.2009.02.024">10.1016/j.ophtha.2009.02.024</ext-link></comment>
<pub-id pub-id-type="pmid">19501409</pub-id></mixed-citation></ref><ref id="pone.0189206.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Ahmed</surname><given-names>Y</given-names></name>, <name><surname>Scott</surname><given-names>IU</given-names></name>, <name><surname>Pathengay</surname><given-names>A</given-names></name>, <name><surname>Bawdekar</surname><given-names>A</given-names></name>, <name><surname>Flynn</surname><given-names>HW</given-names></name>. <article-title>Povidone-iodine for endophthalmitis prophylaxis</article-title>. <source>Am J Ophthalmol</source>. Elsevier; <year>2014</year>;<volume>157</volume>: <fpage>503</fpage>&#x02013;<lpage>504</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ajo.2013.12.001">10.1016/j.ajo.2013.12.001</ext-link></comment>
<pub-id pub-id-type="pmid">24528933</pub-id></mixed-citation></ref><ref id="pone.0189206.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Modjtahedi</surname><given-names>BS</given-names></name>, <name><surname>van Zyl</surname><given-names>T</given-names></name>, <name><surname>Pandya</surname><given-names>HK</given-names></name>, <name><surname>Leonard</surname><given-names>RE</given-names></name>, <name><surname>Eliott</surname><given-names>D</given-names></name>. <article-title>Endophthalmitis After Intravitreal Injections in Patients With Self-reported Iodine Allergy</article-title>. <source>Am J Ophthalmol</source>. Elsevier; <year>2016</year>;<volume>170</volume>: <fpage>68</fpage>&#x02013;<lpage>74</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ajo.2016.07.010">10.1016/j.ajo.2016.07.010</ext-link></comment>
<pub-id pub-id-type="pmid">27448925</pub-id></mixed-citation></ref><ref id="pone.0189206.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>K&#x00131;van&#x000e7;</surname><given-names>SA</given-names></name>, <name><surname>K&#x00131;van&#x000e7;</surname><given-names>M</given-names></name>, <name><surname>Bayramlar</surname><given-names>H</given-names></name>. <article-title>Microbiology of corneal wounds after cataract surgery: biofilm formation and antibiotic resistance patterns</article-title>. <source>J Wound Care</source>. MA Healthcare London; <year>2016</year>;<volume>25</volume>: <fpage>12</fpage>&#x02013;<lpage>14</lpage>&#x02013;9. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.12968/jowc.2016.25.1.12">10.12968/jowc.2016.25.1.12</ext-link></comment>
<pub-id pub-id-type="pmid">26762493</pub-id></mixed-citation></ref><ref id="pone.0189206.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Harun</surname><given-names>S</given-names></name>, <name><surname>Srinivasan</surname><given-names>S</given-names></name>, <name><surname>Hollingworth</surname><given-names>K</given-names></name>, <name><surname>Batterbury</surname><given-names>M</given-names></name>, <name><surname>Kaye</surname><given-names>S</given-names></name>. <article-title>Modification of classification of ocular chemical injuries</article-title>. <source>Br J Ophthalmol</source>. BMJ Publishing Group Ltd; <year>2004</year>;<volume>88</volume>: <fpage>1353</fpage>&#x02013;<lpage>4</lpage>&#x02013; author reply 1354&#x02013;5. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bjo.2004.046797/047308">10.1136/bjo.2004.046797/047308</ext-link></comment>
<pub-id pub-id-type="pmid">15377570</pub-id></mixed-citation></ref><ref id="pone.0189206.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Ferguson</surname><given-names>AW</given-names></name>, <name><surname>Scott</surname><given-names>JA</given-names></name>, <name><surname>McGavigan</surname><given-names>J</given-names></name>, <name><surname>Elton</surname><given-names>RA</given-names></name>, <name><surname>McLean</surname><given-names>J</given-names></name>, <name><surname>Schmidt</surname><given-names>U</given-names></name>, <etal>et al</etal>
<article-title>Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study</article-title>. <source>Br J Ophthalmol</source>. BMJ Group; <year>2003</year>;<volume>87</volume>: <fpage>163</fpage>&#x02013;<lpage>167</lpage>. <pub-id pub-id-type="pmid">12543744</pub-id></mixed-citation></ref><ref id="pone.0189206.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>GERSHENFELD</surname><given-names>L</given-names></name>. <article-title>Povidone-iodine as a sporicide</article-title>. <source>Am J Pharm Sci Support Public Health</source>. <year>1962</year>;<volume>134</volume>: <fpage>78</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="pmid">13898055</pub-id></mixed-citation></ref><ref id="pone.0189206.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>LIANG K-Y</surname><given-names>ZEGER</given-names></name> SL. <source>Longitudinal data analysis using generalized linear models</source>. Biometrika. Oxford University Press; <year>1986</year>;<volume>73</volume>: <fpage>13</fpage>&#x02013;<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/biomet/73.1.13">10.1093/biomet/73.1.13</ext-link></comment></mixed-citation></ref><ref id="pone.0189206.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Liddell</surname><given-names>FD</given-names></name>. <article-title>Simplified exact analysis of case-referent studies: matched pairs; dichotomous exposure. J Epidemiol Community Health</article-title>. <source>BMJ Publishing Group Ltd</source>; <year>1983</year>;<volume>37</volume>: <fpage>82</fpage>&#x02013;<lpage>84</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/jech.37.1.82">10.1136/jech.37.1.82</ext-link></comment></mixed-citation></ref><ref id="pone.0189206.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Sakpal</surname><given-names>TV</given-names></name>. <article-title>Sample size estimation in clinical trial</article-title>. <source>Perspect Clin Res</source>. <year>2010</year>;<volume>1</volume>: <fpage>67</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="pmid">21829786</pub-id></mixed-citation></ref><ref id="pone.0189206.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Cimmino</surname><given-names>T</given-names></name>, <name><surname>Le Page</surname><given-names>S</given-names></name>, <name><surname>Raoult</surname><given-names>D</given-names></name>, <name><surname>Rolain J-</surname><given-names>M</given-names></name>. <article-title>Contemporary challenges and opportunities in the diagnosis and outbreak detection of multidrug-resistant infectious disease</article-title>. <source>Expert Review of Molecular Diagnostics</source>. Taylor &#x00026; Francis; <year>2016</year>;: 14737159.2016.1244005&#x02013;13. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/14737159.2016.1244005">10.1080/14737159.2016.1244005</ext-link></comment>
<pub-id pub-id-type="pmid">27690721</pub-id></mixed-citation></ref><ref id="pone.0189206.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Bhat</surname><given-names>SS</given-names></name>, <name><surname>Undrakonda</surname><given-names>V</given-names></name>, <name><surname>Mukhopadhyay</surname><given-names>C</given-names></name>, <name><surname>Parmar</surname><given-names>PV</given-names></name>. <article-title>Outbreak of multidrug-resistant acute postoperative endophthalmitis due to Enterobacter aerogenes</article-title>. <source>Ocul Immunol Inflamm</source>. <year>2014</year>;<volume>22</volume>: <fpage>121</fpage>&#x02013;<lpage>126</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/09273948.2013.830752">10.3109/09273948.2013.830752</ext-link></comment>
<pub-id pub-id-type="pmid">24063692</pub-id></mixed-citation></ref><ref id="pone.0189206.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Deng</surname><given-names>C</given-names></name>, <name><surname>Zhang</surname><given-names>W</given-names></name>, <name><surname>Yuan</surname><given-names>Y</given-names></name>, <name><surname>Yao</surname><given-names>A</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name>, <name><surname>Yu</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Report: Prevention infection of newborn nosocomial and distribution of multiple drug resistant organism of the medicinal</article-title>. <source>Pak J Pharm Sci</source>. <year>2016</year>;<volume>29</volume>: <fpage>361</fpage>&#x02013;<lpage>365</lpage>. <pub-id pub-id-type="pmid">27005503</pub-id></mixed-citation></ref><ref id="pone.0189206.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Tsitsopoulos</surname><given-names>PP</given-names></name>, <name><surname>Iosifidis</surname><given-names>E</given-names></name>, <name><surname>Antachopoulos</surname><given-names>C</given-names></name>, <name><surname>Anestis</surname><given-names>DM</given-names></name>, <name><surname>Karantani</surname><given-names>E</given-names></name>, <name><surname>Karyoti</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Nosocomial bloodstream infections in neurosurgery: a 10-year analysis in a center with high antimicrobial drug-resistance prevalence</article-title>. <source>Acta Neurochir</source>. Springer Vienna; <year>2016</year>;<volume>158</volume>: <fpage>1647</fpage>&#x02013;<lpage>1654</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00701-016-2890-5">10.1007/s00701-016-2890-5</ext-link></comment>
<pub-id pub-id-type="pmid">27452903</pub-id></mixed-citation></ref><ref id="pone.0189206.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Nentwich</surname><given-names>MM</given-names></name>, <name><surname>Kollmann</surname><given-names>KHM</given-names></name>, <name><surname>Meshack</surname><given-names>J</given-names></name>, <name><surname>Ilako</surname><given-names>DR</given-names></name>, <name><surname>Schaller</surname><given-names>UC</given-names></name>. <article-title>Microbial contamination of multi-use ophthalmic solutions in Kenya</article-title>. <source>Br J Ophthalmol</source>. BMJ Publishing Group Ltd; <year>2007</year>;<volume>91</volume>: <fpage>1265</fpage>&#x02013;<lpage>1268</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bjo.2007.116897">10.1136/bjo.2007.116897</ext-link></comment>
<pub-id pub-id-type="pmid">17475714</pub-id></mixed-citation></ref><ref id="pone.0189206.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Mastropasqua</surname><given-names>L</given-names></name>. <article-title>Collagen cross-linking: when and how? A review of the state of the art of the technique and new perspectives</article-title>. <source>Eye and Vis. JAMA</source> &#x02026;; <year>2015</year>;<volume>2</volume>: <fpage>842</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s40662-015-0030-6">10.1186/s40662-015-0030-6</ext-link></comment>
<pub-id pub-id-type="pmid">26665102</pub-id></mixed-citation></ref><ref id="pone.0189206.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Inoue</surname><given-names>Y</given-names></name>, <name><surname>Usui</surname><given-names>M</given-names></name>, <name><surname>Ohashi</surname><given-names>Y</given-names></name>, <name><surname>Shiota</surname><given-names>H</given-names></name>, <name><surname>Yamazaki</surname><given-names>T</given-names></name>, <article-title>Preoperative Disinfection Study Group. Preoperative disinfection of the conjunctival sac with antibiotics and iodine compounds: a prospective randomized multicenter study</article-title>. <source>Jpn J Ophthalmol</source>. Springer Japan; <year>2008</year>;<volume>52</volume>: <fpage>151</fpage>&#x02013;<lpage>161</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10384-008-0517-y">10.1007/s10384-008-0517-y</ext-link></comment>
<pub-id pub-id-type="pmid">18661264</pub-id></mixed-citation></ref><ref id="pone.0189206.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Cornut P-</surname><given-names>L</given-names></name>, <name><surname>Chiquet</surname><given-names>C</given-names></name>. [<article-title>Intravitreal injection of antibiotics in endophthalmitis</article-title>]. <source>J Fr Ophtalmol</source>. <year>2008</year>;<volume>31</volume>: <fpage>815</fpage>&#x02013;<lpage>823</lpage>. <pub-id pub-id-type="pmid">19107050</pub-id></mixed-citation></ref><ref id="pone.0189206.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Rudnisky</surname><given-names>CJ</given-names></name>, <name><surname>Wan</surname><given-names>D</given-names></name>, <name><surname>Weis</surname><given-names>E</given-names></name>. <article-title>Antibiotic choice for the prophylaxis of post-cataract extraction endophthalmitis</article-title>. <source>Ophthalmology</source>. Elsevier; <year>2014</year>;<volume>121</volume>: <fpage>835</fpage>&#x02013;<lpage>841</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ophtha.2013.08.046">10.1016/j.ophtha.2013.08.046</ext-link></comment>
<pub-id pub-id-type="pmid">24326107</pub-id></mixed-citation></ref><ref id="pone.0189206.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Miller</surname><given-names>D</given-names></name>, <name><surname>Flynn</surname><given-names>PM</given-names></name>, <name><surname>Scott</surname><given-names>IU</given-names></name>, <name><surname>Alfonso</surname><given-names>EC</given-names></name>, <name><surname>Flynn</surname><given-names>HW</given-names></name>. <article-title>In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates</article-title>. <source>Arch Ophthalmol</source>. American Medical Association; <year>2006</year>;<volume>124</volume>: <fpage>479</fpage>&#x02013;<lpage>483</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/archopht.124.4.479">10.1001/archopht.124.4.479</ext-link></comment>
<pub-id pub-id-type="pmid">16606872</pub-id></mixed-citation></ref><ref id="pone.0189206.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>de Kaspar</surname><given-names>HM</given-names></name>, <name><surname>Chang</surname><given-names>RT</given-names></name>, <name><surname>Singh</surname><given-names>K</given-names></name>, <name><surname>Egbert</surname><given-names>PR</given-names></name>, <name><surname>Blumenkranz</surname><given-names>MS</given-names></name>, <name><surname>Ta</surname><given-names>CN</given-names></name>. <article-title>Prospective Randomized Comparison of 2 Different Methods of 5% Povidone-Iodine Applications for Anterior Segment Intraocular Surgery</article-title>. <source>Arch Ophthalmol</source>. American Medical Association; <year>2005</year>;<volume>123</volume>: <fpage>161</fpage>&#x02013;<lpage>165</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/archopht.123.2.161">10.1001/archopht.123.2.161</ext-link></comment>
<pub-id pub-id-type="pmid">15710810</pub-id></mixed-citation></ref><ref id="pone.0189206.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Silas</surname><given-names>MR</given-names></name>, <name><surname>Schroeder</surname><given-names>RM</given-names></name>, <name><surname>Thomson</surname><given-names>RB</given-names></name>, <name><surname>Myers</surname><given-names>WG</given-names></name>. <article-title>Optimizing the antisepsis protocol: Effectiveness of 3 povidone&#x02013;iodine 1.0% applications versus a single application of povidone&#x02013;iodine 5.0%</article-title>. <source>J Cataract Refract Surg</source>. <year>2017</year>;<volume>43</volume>: <fpage>400</fpage>&#x02013;<lpage>404</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jcrs.2017.01.007">10.1016/j.jcrs.2017.01.007</ext-link></comment>
<pub-id pub-id-type="pmid">28410725</pub-id></mixed-citation></ref><ref id="pone.0189206.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Apt</surname><given-names>L</given-names></name>, <name><surname>Isenberg</surname><given-names>S</given-names></name>, <name><surname>Yoshimori</surname><given-names>R</given-names></name>, <name><surname>Paez</surname><given-names>JH</given-names></name>. <article-title>Chemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva</article-title>. <source>Arch Ophthalmol</source>. <year>1984</year>;<volume>102</volume>: <fpage>728</fpage>&#x02013;<lpage>729</lpage>. <pub-id pub-id-type="pmid">6721765</pub-id></mixed-citation></ref><ref id="pone.0189206.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Isenberg</surname><given-names>SJ</given-names></name>, <name><surname>Apt</surname><given-names>L</given-names></name>, <name><surname>Yoshimori</surname><given-names>R</given-names></name>, <name><surname>Khwarg</surname><given-names>S</given-names></name>. <article-title>Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic</article-title>. <source>Arch Ophthalmol</source>. <year>1985</year>;<volume>103</volume>: <fpage>1340</fpage>&#x02013;<lpage>1342</lpage>. <pub-id pub-id-type="pmid">2994609</pub-id></mixed-citation></ref><ref id="pone.0189206.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Hosseini</surname><given-names>H</given-names></name>, <name><surname>Ashraf</surname><given-names>MJ</given-names></name>, <name><surname>Saleh</surname><given-names>M</given-names></name>, <name><surname>Nowroozzadeh</surname><given-names>MH</given-names></name>, <name><surname>Nowroozizadeh</surname><given-names>B</given-names></name>, <name><surname>Abtahi</surname><given-names>MB</given-names></name>, <etal>et al</etal>
<article-title>Effect of povidone-iodine concentration and exposure time on bacteria isolated from endophthalmitis cases</article-title>. <source>J Cataract Refract Surg</source>. Elsevier; <year>2012</year>;<volume>38</volume>: <fpage>92</fpage>&#x02013;<lpage>96</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jcrs.2011.06.030">10.1016/j.jcrs.2011.06.030</ext-link></comment>
<pub-id pub-id-type="pmid">21983301</pub-id></mixed-citation></ref><ref id="pone.0189206.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Nentwich</surname><given-names>MM</given-names></name>, <name><surname>Ta</surname><given-names>CN</given-names></name>, <name><surname>Kreutzer</surname><given-names>TC</given-names></name>, <name><surname>Li</surname><given-names>B</given-names></name>, <name><surname>Schwarzbach</surname><given-names>F</given-names></name>, <name><surname>Yactayo-Miranda</surname><given-names>YM</given-names></name>, <etal>et al</etal>
<article-title>Incidence of postoperative endophthalmitis from 1990 to 2009 using povidone-iodine but no intracameral antibiotics at a single academic institution</article-title>. <source>J Cataract Refract Surg</source>. Elsevier; <year>2015</year>;<volume>41</volume>: <fpage>58</fpage>&#x02013;<lpage>66</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jcrs.2014.04.040">10.1016/j.jcrs.2014.04.040</ext-link></comment>
<pub-id pub-id-type="pmid">25532634</pub-id></mixed-citation></ref><ref id="pone.0189206.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Mac Rae</surname><given-names>SM</given-names></name>, <name><surname>Brown</surname><given-names>B</given-names></name>, <name><surname>Edelhauser</surname><given-names>HF</given-names></name>. <article-title>The corneal toxicity of presurgical skin antiseptics</article-title>. <source>Am J Ophthalmol</source>. <year>1984</year>;<volume>97</volume>: <fpage>221</fpage>&#x02013;<lpage>232</lpage>. <pub-id pub-id-type="pmid">6696033</pub-id></mixed-citation></ref><ref id="pone.0189206.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Wille</surname><given-names>H</given-names></name>. <article-title>Assessment of possible toxic effects of polyvinylpyrrolidone-iodine upon the human eye in conjunction with cataract extraction. An endothelial specular microscope study</article-title>. <source>Acta Ophthalmol (Copenh)</source>. <year>1982</year>;<volume>60</volume>: <fpage>955</fpage>&#x02013;<lpage>960</lpage>.<pub-id pub-id-type="pmid">7170937</pub-id></mixed-citation></ref></ref-list></back></article>